← Open Payments lookup

STEPHANIE CALLAWAY: Open Payments

NPI 1730616921 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,847 in 98 payments from 21 companies in 2025. Trend: 2023 $1,220 · 2024 $1,314 · 2025 $1,847

Food & beverage: $1,847
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP10$215
ABBVIE INC.14$206
Lilly USA, LLC11$200
Novo Nordisk Inc9$188
PFIZER INC.11$174
GlaxoSmithKline, LLC.9$154
Astellas Pharma US Inc5$93
Takeda Pharmaceuticals U.S.A., Inc.6$92
Abbott Laboratories3$77
Corcept Therapeutics2$69

Products named: JARDIANCE, QULIPTA, ELIQUIS, AIRSUPRA, MOUNJARO, TRELEGY ELLIPTA, Veozah, TRINTELLIX.

Industry payments across TX — which companies pay providers there.